Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 85/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 1
2(50.0%)
4Total
N/A(2)
Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04232774Not ApplicableCompleted

Neurotronic Ablation of Arteries for the Treatment of Type 2 Diabetes Mellitus and Its Comorbidities

Role: lead

NCT05369065Phase 1Recruiting

Ablation of Arteries for the Treatment of Type 2 Diabetes Mellitus and Its Comorbidities

Role: lead

NCT05363761Phase 1Recruiting

Arterial Ablation for the Treatment of Type 2 Diabetes Mellitus and Its Comorbidities

Role: lead

NCT03675074Not ApplicableWithdrawn

Neujia Anastomosis for Treatment of Obesity and Type II Diabetes

Role: lead

All 4 trials loaded